Can You Stay on 2.5 mg Zepbound? What the Label Says

Direct answer: Current Zepbound prescribing information says 2.5 mg once weekly is the four-week initiation dose and is not approved as a maintenance dose. The labeled maintenance doses for weight reduction are 5 mg, 10 mg, or 15 mg once weekly. Do not stay, escalate, restart, or stop based only on online advice; ask the prescriber about tolerability and the next dose.

The labeled Zepbound schedule

Later increases are made in 2.5 mg increments only after at least four weeks on the current dose. The label tells prescribers to consider response and tolerability when selecting a maintenance dose.

Why 2.5 mg is called an initiation dose

The escalation schedule is designed to reduce gastrointestinal adverse reactions while treatment begins. Feeling appetite effects or losing weight during the first month does not change the label's statement that 2.5 mg is not an approved maintenance dosage.

“Not approved as maintenance” does not tell a reader what to do with an individual prescription. It means the current FDA-reviewed maintenance schedule does not include 2.5 mg.

When to contact the prescriber before escalating

• Nausea, vomiting, diarrhea, constipation, or abdominal symptoms are persistent or worsening.
• Eating or drinking enough is difficult, or there are signs of dehydration.
• Another glucose-lowering medicine raises hypoglycemia concerns.
• A dose was missed, treatment was interrupted, or the next strength is unavailable.
• The prescription is for obstructive sleep apnea, where the labeled maintenance doses differ.

Seek prompt medical care for severe or persistent abdominal pain, serious allergic-reaction symptoms, or other rapidly worsening symptoms described in the Medication Guide.

Why early weight loss does not establish long-term dosing

An individual's first-month scale change cannot establish that 2.5 mg has proven long-term maintenance efficacy. Early results can reflect fluid, food intake, gastrointestinal effects, and other factors. The relevant decision is whether the clinician's ongoing plan is safe, tolerable, and consistent with the approved indication or a documented individualized rationale.

Insurance and cost do not change the labeled dose

Coverage rules, savings eligibility, and pharmacy availability may influence access, but they do not convert 2.5 mg into an approved maintenance dose. Do not split pens, stretch intervals, transfer medicine, or use an unlabeled partial-dose method to reduce cost.

Questions to bring to the prescriber

• Which indication am I being treated for, and what is the target maintenance dose?
• Which symptoms are expected during escalation, and which require a call?
• Should escalation be delayed because of my response, side effects, or other medicines?
• If treatment was interrupted, what restart plan applies?
• What should I do if the prescribed strength is unavailable or not covered?

Frequently asked questions

Can 2.5 mg Zepbound be a maintenance dose?

Not under the current FDA-approved labeling. It is the initiation dose for the first four weeks.

What is the lowest approved maintenance dose for weight reduction?

5 mg once weekly.

What if 2.5 mg is already causing side effects?

Contact the prescriber before escalating or taking another dose if symptoms are significant or worsening.

Can I stay on 2.5 mg because I am already losing weight?

Early response does not make 2.5 mg an approved maintenance dose. Discuss the response and tolerability with the prescriber.

Primary sources

• Current Zepbound prescribing information and Medication Guide
• FDA, Zepbound chronic weight-management approval

Evidence review completed August 1, 2026.